Amylyx Pharmaceuticals, Inc. (AMLX)
| Previous Close | 4.6600 |
| Open | 4.6600 |
| Bid | 0.0000 x 0 |
| Ask | 0.0000 x 0 |
| Day's Range | 4.4500 - 4.7600 |
| 52 Week Range | 1.5750 - 19.9490 |
| Volume | |
| Avg. Volume | 1,217,887 |
| Market Cap | 315.903M |
| Beta (5Y Monthly) | -0.55 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -2.4600 |
| Earnings Date | Aug 08, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 4.37 |
Simply Wall St.October 2024's US Penny Stocks Poised For Growth
As major U.S. stock indexes experience a slight dip from record highs amid a busy earnings season, investors are closely monitoring the economic landscape for signs of stability and growth. In this context, penny stocks—often associated with smaller or newer companies—remain an intriguing investment area despite their somewhat outdated label. These stocks can offer a blend of affordability and potential growth when backed by strong financials, making them worthy of consideration for those...
Insider MonkeyAmylyx Pharmaceuticals (AMLX): Leading Nano Cap in Neurodegenerative Disease Treatments
We recently published a list of 7 Best Nano Cap Stocks To Invest In. In this article, we are going to take a look at where Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) stands against other best nano cap stocks to invest in. What Are the Small Cap Bulls Saying? In one of our recent articles about 8 Most […]
